Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Eisai Inc.
ClinicalTrials.gov Identifier:
NCT00374660
First received: September 8, 2006
Last updated: June 30, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)